Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 106, Issue 11, Pages 3316-3327Publisher
WILEY
DOI: 10.1016/j.xphs.2017.06.013
Keywords
electrospray; PLGA; peptide encapsulation; vaccine; controlled drug delivery
Funding
- European EFRE funds
- state of Mecklenburg-Vorpommern [V-630-VB264-2012/117]
Ask authors/readers for more resources
Polymer nanoparticles (NP) are of escalating interest for their application as immune stimulatory pharmaceutics. The production of nanosized carrier systems is currently being widely investigated, but commonly used techniques, such as the double emulsion technique, are limited by shortcomings of low encapsulation efficiency and poor control over size distribution. In this study, the electrospray technique was successfully implemented and optimized to produce monodisperse 200-nm poly(lactide-coglycolide) (PLGA) NP. For cytomegalovirus (CMV) pp65 and IE-1 peptides, a consistent encapsulation efficiency of approximately 85% was achieved. In vitro stimulation of peripheral blood mononuclear cells (PBMCs) from CMV+ donors using electrosprayed pp65(489-503) peptideeloaded NP revealed a significantly increased proliferation rate and frequency of antigen-specific CD8(+) T cells as compared to the soluble peptide. The results of this study demonstrate the suitability of the electrospray technique for production of monodisperse PLGA NP with high drug encapsulation efficiency as promising peptide-based vaccine carriers. (C) 2017 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available